Alene McCoy, Ph.D. - Publications
Affiliations: | 2010 | Washington State University, Pullman, WA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2014 | Murphy L, LeBaron M, Marshall V, McCoy A, Kan L, Boverhof D, Bartels M, Terry C, Billington R, Rasoulpour R. Aryl hydrocarbon receptor mode-of-action and human relevance framework for halauxifen-methyl induced rodent liver effects Toxicology Letters. 229: S218. DOI: 10.1016/J.Toxlet.2014.06.733 | 0.304 | |||
2013 | McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of Pharmacology and Experimental Therapeutics. 344: 141-54. PMID 23055539 DOI: 10.1124/Jpet.112.199497 | 0.677 | |||
2012 | Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/Jpet.111.188136 | 0.612 | |||
2010 | Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW. The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 333: 161-73. PMID 20086056 DOI: 10.1124/Jpet.109.161711 | 0.477 | |||
Show low-probability matches. |